We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
International Seaways
INSW
$4.57B
| $53.8K | ﹤0.01% |
703
| – | – |
|
1302
Xometry
XMTR
$4.77B
| $53.8K | ﹤0.01% |
558
-26
| -4% | -$1.86K |
|
|
ADAM
1303
Adamas Trust
ADAM
$777M
| $53.7K | ﹤0.01% |
5,723
| – | – |
|
1304
Corpay
CPAY
$24.2B
| $53.7K | ﹤0.01% |
161
-1
| -0.6% | -$332 |
|
1305
Fulton Financial
FULT
$4.7B
| $53.6K | ﹤0.01% |
2,217
| – | – |
|
1306
InvenTrust Properties
IVT
$2.84B
| $53.6K | ﹤0.01% |
1,513
| – | – |
|
1307
NOV
NOV
$7.45B
| $53.5K | ﹤0.01% |
2,885
+465
| +19% | +$9.27K |
|
1308
Domino's
DPZ
$11B
| $53.3K | ﹤0.01% |
180
-581
| -76% | -$191K |
|
1309
Liberty Global Class C
LBTYK
$3.27B
| $53.2K | ﹤0.01% |
4,834
+2,292
| +90% | +$26.5K |
|
1310
Concentrix
CNXC
$1.36B
| $53K | ﹤0.01% |
2,367
-4,929
| -68% | -$129K |
|
1311
Home BancShares
HOMB
$6.21B
| $53K | ﹤0.01% |
1,857
+1,124
| +153% | +$30.5K |
|
1312
LPL Financial
LPLA
$26.3B
| $53K | ﹤0.01% |
188
+83
| +79% | +$24.9K |
|
1313
Hilton Grand Vacations
HGV
$3.84B
| $52.8K | ﹤0.01% |
1,009
-20
| -2% | -$965 |
|
1314
Fair Isaac
FICO
$28.7B
| $52.6K | ﹤0.01% |
44
+24
| +120% | +$26.9K |
|
1315
Exponent
EXPO
$2.98B
| $52.5K | ﹤0.01% |
894
-332
| -27% | -$20.4K |
|
1316
CNA Financial
CNA
$14.5B
| $52.5K | ﹤0.01% |
1,080
-598
| -36% | -$27.2K |
|
1317
Omega Flex
OFLX
$298M
| $52.4K | ﹤0.01% |
1,670
+1,505
| +912% | +$46.7K |
|
1318
AZZ Inc
AZZ
$4.5B
| $52.4K | ﹤0.01% |
338
| – | – |
|
1319
Liberty Live Group Series A
LLYVA
$8.8B
| $52.4K | ﹤0.01% |
517
-209
| -29% | -$19.8K |
|
|
OSG
1320
Octave Specialty Group
OSG
$252M
| $52.2K | ﹤0.01% |
+8,360
| New | +$43.5K |
|
1321
Accel Entertainment
ACEL
$979M
| $52.1K | ﹤0.01% |
4,134
+142
| +4% | +$1.72K |
|
1322
BOK Financial
BOKF
$8.64B
| $52.1K | ﹤0.01% |
375
+121
| +48% | +$16K |
|
1323
Cathay General Bancorp
CATY
$4.2B
| $52K | ﹤0.01% |
839
-8
| -0.9% | -$454 |
|
1324
Crescent Energy
CRGY
$3.72B
| $52K | ﹤0.01% |
5,293
+667
| +14% | +$8.15K |
|
1325
Uranium Energy
UEC
$4.71B
| $52K | ﹤0.01% |
4,875
| – | – |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.